{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:42:42Z","timestamp":1789609362972,"version":"build-2803163510"},"reference-count":26,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/10428194.2026.2665793","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:37:52Z","timestamp":1779453472000},"page":"1788-1795","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Real-world venetoclax dosing patterns and treatment persistence in patients with acute myeloid leukemia: a community pharmacy database study in Japan"],"prefix":"10.1080","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4596-3663","authenticated-orcid":false,"given":"Yuki","family":"Goshima","sequence":"first","affiliation":[{"name":"Department of Hematology, Nippon Medical School","place":["Tokyo, Japan"]},{"name":"Interdisciplinary Theoretical and Mathematical Sciences (iTHEMS) Program, RIKEN","place":["Wako, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-3244","authenticated-orcid":false,"given":"Tomoya","family":"Saika","sequence":"additional","affiliation":[{"name":"Patient Engagement Frontier Medical Science, KAKEHASHI Inc","place":["Tokyo, Japan"]},{"name":"Graduate School of Medical and Pharmaceutical Sciences, Chiba University","place":["Chiba, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9511-0435","authenticated-orcid":false,"given":"Yuki","family":"Kado","sequence":"additional","affiliation":[{"name":"Patient Engagement Frontier Medical Science, KAKEHASHI Inc","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2866-9553","authenticated-orcid":false,"given":"Michiko","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School","place":["Tokyo, Japan"]},{"name":"Patient Engagement Frontier Medical Science, KAKEHASHI Inc","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-5139","authenticated-orcid":false,"given":"Tohru","family":"Takebe","sequence":"additional","affiliation":[{"name":"Patient Engagement Frontier Medical Science, KAKEHASHI Inc","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-4997","authenticated-orcid":false,"given":"Shunsuke","family":"Yui","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae): acute myeloid leukemia. version 2.2026. Plymouth Meeting (PA): National Comprehensive Cancer Network.2026. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1411."},{"key":"e_1_3_5_3_1","volume-title":"Guidelines for hematologic malignancies 2024 (Version 3.1)","author":"Japanese Society of Hematology","year":"2024","unstructured":"Japanese Society of Hematology. Guidelines for hematologic malignancies 2024 (Version 3.1). Tokyo: Japanese Society of Hematology; 2024. Available from: https:\/\/www.jshem.or.jp\/gui-hemali\/table.html. In Japanese."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"issue":"8","key":"e_1_3_5_6_1","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano L","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, et\u00a0al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068\u20131075.","journal-title":"Haematologica"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00374"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061094"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/598327"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.730"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13175"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.01.003"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00073-4"},{"key":"e_1_3_5_14_1","volume-title":"Drugs@FDA: VENCLEXTA (venetoclax) tablets (NDA 208573)","author":"U.S. Food and Drug Administration","unstructured":"U.S. Food and Drug Administration. Drugs@FDA: VENCLEXTA (venetoclax) tablets (NDA 208573). Silver Spring (MD): FDA; 2016. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=208573"},{"key":"e_1_3_5_15_1","volume-title":"Venclexta tablets (venetoclax): package insert","author":"Pharmaceuticals and Medical Devices Agency (PMDA)","unstructured":"Pharmaceuticals and Medical Devices Agency (PMDA). Venclexta tablets (venetoclax): package insert. Tokyo: PMDA; 2025. Available from: https:\/\/www.info.pmda.go.jp\/go\/pack\/4291062F3023_1_09\/?view=frame&style=XML&lang=ja."},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0612-8"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107341"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-025-00329-3"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-025-04093-y"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01324-7"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05102-y"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14302"},{"key":"e_1_3_5_23_1","first-page":"1027","volume-title":"Proceedings of the eighteenth annual ACM-SIAM symposium on discrete algorithms (SODA 2007)","author":"Arthur D","year":"2007","unstructured":"Arthur D, Vassilvitskii S. k-means++: the advantages of careful seeding In Proceedings of the eighteenth annual ACM-SIAM symposium on discrete algorithms (SODA 2007). 2007. New Orleans, LA. Philadelphia (PA): Society for Industrial and Applied Mathematics. 1027\u20131035."},{"key":"e_1_3_5_24_1","unstructured":"Certara. Drug interaction database (DIDB\u00ae). Princeton (NJ): Certara. Available from: https:\/\/www.certara.com\/drug-interaction-database-didb\/."},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6430"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-868752"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12500"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2665793","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10428194.2026.2665793","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2665793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:01:54Z","timestamp":1782946914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2026.2665793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/10428194.2026.2665793"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2026.2665793","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}